Close

Analyst Ratings for Biohaven Pharmaceutical Holding (BHVN) [Neutrals]

BHVN Rating Summary

BHVN Price Target Summary

* Over Last 12-Mos
  |   Expand Research on BHVN
Overall Rating: BUY   Rating Trend: Up   Avg. $ Target: $59.50 (+59.2%) * Over Last 12-Mos
Rating Score: 7.8 / 10   Percentile Rank: 82%
Date Firm Analyst Type Rating
(Past)
PT
(Past)
Start $
(End $)
% Chg. Details
8/8/2022 Wedbush Laura Chico Downgrade Neutral
(Outperform)
148.50
(N/A)
146.98
(37.37)
-74.57% Details
2/10/2020 Oppenheimer Esther Rajavelu Downgrade Perform
(Outperform)
51.00
(67.00)
51.25
(37.37)
-27.08% Details